Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19.
- DOI
- 10.1038/s41564-026-02285-8
- Published
- 2026 Apr
- Container
- Nature microbiology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41564-026-02285-8,
title = {Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19.},
author = {Glascock A and Maguire C and Phan HV and Lydon EC and Schaenman J and Calfee CS and Melamed E and Greenland J and Corry DB and Kheradmand F and Baden LR and Sekaly R and McComsey GA and Haddad EK and Cairns CB and Geng LN and Pulendran B and Fernandez-Sesma A and Simon V and Metcalf JP and Agudelo Higuita NI and Messer WB and Davis MM and Nadeau KC and Kraft M and Bime C and Erle DJ and Atkinson MA and Brakenridge SC and Ehrlich LIR and Montgomery RR and Shaw AC and Hough CL and Hafler DA and Augustine AD and Becker PM and Peters B and Ozonoff A and Hoch A and Kim-Schulze S and Krammer F and Bosinger S and Eckalbar W and Altman MC and Wilson M and Guan L and Maecker H and Steen H and IMPACC Network and Diray-Arce J and Rouphael N and Kleinstein SH and Jayavelu ND and Reed EF and Levy O and Chu VT and Langelier CR},
year = {2026},
journal = {Nature microbiology},
doi = {10.1038/s41564-026-02285-8},
url = {https://doi.org/10.1038/s41564-026-02285-8}
}RIS
TY - JOUR TI - Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19. AU - Glascock A AU - Maguire C AU - Phan HV AU - Lydon EC AU - Schaenman J AU - Calfee CS AU - Melamed E AU - Greenland J AU - Corry DB AU - Kheradmand F AU - Baden LR AU - Sekaly R AU - McComsey GA AU - Haddad EK AU - Cairns CB AU - Geng LN AU - Pulendran B AU - Fernandez-Sesma A AU - Simon V AU - Metcalf JP AU - Agudelo Higuita NI AU - Messer WB AU - Davis MM AU - Nadeau KC AU - Kraft M AU - Bime C AU - Erle DJ AU - Atkinson MA AU - Brakenridge SC AU - Ehrlich LIR AU - Montgomery RR AU - Shaw AC AU - Hough CL AU - Hafler DA AU - Augustine AD AU - Becker PM AU - Peters B AU - Ozonoff A AU - Hoch A AU - Kim-Schulze S AU - Krammer F AU - Bosinger S AU - Eckalbar W AU - Altman MC AU - Wilson M AU - Guan L AU - Maecker H AU - Steen H AU - IMPACC Network AU - Diray-Arce J AU - Rouphael N AU - Kleinstein SH AU - Jayavelu ND AU - Reed EF AU - Levy O AU - Chu VT AU - Langelier CR PY - 2026 JO - Nature microbiology DO - 10.1038/s41564-026-02285-8 UR - https://doi.org/10.1038/s41564-026-02285-8 ER -
APA
A, G., C, M., HV, P., EC, L., J, S., CS, C., E, M., J, G., DB, C., F, K., LR, B., R, S., GA, M., EK, H., CB, C., LN, G., B, P., A, F., V, S., JP, M., NI, A. H., WB, M., MM, D., KC, N., M, K., C, B., DJ, E., MA, A., SC, B., LIR, E., RR, M., AC, S., CL, H., DA, H., AD, A., PM, B., B, P., A, O., A, H., S, K., F, K., S, B., W, E., MC, A., M, W., L, G., H, M., H, S., Network, I., J, D., N, R., SH, K., ND, J., EF, R., O, L., VT, C., & CR, L. (2026). Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19.. Nature microbiology. https://doi.org/10.1038/s41564-026-02285-8
Source records
- pubmed · retrieved 2026-09-26T01:46:25.766Z